SCHEMBL3401892

SCHEMBL3401892

Cc1ccc([N+](=O)[O-])cc1[N+]#N.F[B-](F)(F)F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.53
TSHR P16473 4/20 0.53
TDP1 Q9NUW8 3/20 0.53
CYP3A4 P08684 3/20 0.49
PDE2A O00408 1/20 0.42
PDE5A O76074 1/20 0.42
ALOX15 P16050 1/20 0.42
NFKB1 P19838 1/20 0.42
APEX1 P27695 1/20 0.42
PDE4A P27815 1/20 0.42
BLM P54132 1/20 0.42
PDE1B Q01064 1/20 0.42
PMP22 Q01453 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4D Q08499 1/20 0.42
PDE7A Q13946 1/20 0.42
PDE1C Q14123 1/20 0.42
PDE7B Q9NP56 1/20 0.42
ACHE P22303 3/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31125088 1.00 ALDH1A1 (0.53) ALDH1A1TSHRTDP1CYP3A4PDE2A
SCHEMBL6650087 0.93 ALDH1A1 (0.60) ALDH1A1TSHRTDP1CYP3A4PDE2A
SCHEMBL28796478 0.93 ALDH1A1 (0.60) ALDH1A1TSHRTDP1CYP3A4PDE2A
Sulfuric Acid SCHEMBL8930779 0.87 ALDH1A1 (0.53) ALDH1A1TSHRTDP1CYP3A4PDE2A
SCHEMBL11430708 0.87 ALDH1A1 (0.53) ALDH1A1TSHRTDP1CYP3A4PDE2A
Sulfuric Acid SCHEMBL8930784 0.86 ALDH1A1 (0.51) ALDH1A1TSHRTDP1CYP3A4PDE2A
Sulfuric Acid SCHEMBL8930788 0.84 ALDH1A1 (0.50) ALDH1A1TSHRTDP1CYP3A4PDE2A
SCHEMBL14744354 0.81 HSD17B10 (0.53) ALDH1A1TSHRTDP1CYP3A4ALOX15
SCHEMBL29494947 0.81 HSD17B10 (0.53) ALDH1A1TSHRTDP1CYP3A4ALOX15
SCHEMBL6650089 0.80 ALDH1A1 (0.60) ALDH1A1TSHRTDP1CYP3A4PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110053935-A1 FUSED PYRIDINES ACTIVE AS INHIBITORS OF C-MET F. HOFFMANN-LA ROCHE AG (CH) 2011-03-03 US disclosed
EP-2247584-A1 FUSED PYRIDINES ACTIVE AS INHIBITORS OF C-MET F. Hoffmann-La Roche AG (CH) 2010-11-10 EP disclosed
WO-2009093049-A1 FUSED PYRIDINES ACTIVE AS INHIBITORS OF C-MET F. HOFFMANN-LA ROCHE AG (CH) 2009-07-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053935-A1 FUSED PYRIDINES ACTIVE AS INHIBITORS OF C-MET MET, ROS1, ABL1 ALDH1A1 550/4885TSHR 1903/4885TDP1 4265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.